X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5266) 5266
Publication (414) 414
Book Review (127) 127
Newsletter (118) 118
Newspaper Article (30) 30
Magazine Article (14) 14
Trade Publication Article (4) 4
Book Chapter (3) 3
Dissertation (3) 3
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4481) 4481
fluticasone (3120) 3120
male (2550) 2550
female (2474) 2474
administration, inhalation (2372) 2372
index medicus (2166) 2166
fluticasone propionate (2096) 2096
asthma - drug therapy (2000) 2000
asthma (1994) 1994
adult (1824) 1824
androstadienes - administration & dosage (1677) 1677
middle aged (1583) 1583
respiratory system (1527) 1527
corticosteroids (1387) 1387
treatment outcome (1197) 1197
budesonide (1069) 1069
aged (1065) 1065
child (1063) 1063
adolescent (1030) 1030
double-blind method (1019) 1019
allergy (994) 994
bronchodilator agents - administration & dosage (928) 928
androstadienes - therapeutic use (915) 915
adrenal cortex hormones - administration & dosage (868) 868
inhaled corticosteroids (857) 857
immunology (839) 839
pulmonary disease, chronic obstructive - drug therapy (813) 813
drug therapy (797) 797
salmeterol (794) 794
pharmacology & pharmacy (792) 792
anti-inflammatory agents - administration & dosage (779) 779
anti-asthmatic agents - administration & dosage (740) 740
children (709) 709
drug therapy, combination (697) 697
double-blind (655) 655
albuterol - analogs & derivatives (641) 641
efficacy (601) 601
bronchodilator agents - therapeutic use (598) 598
obstructive pulmonary-disease (582) 582
asthma - physiopathology (578) 578
steroids (575) 575
androstadienes - adverse effects (571) 571
dosage and administration (547) 547
beclomethasone dipropionate (540) 540
dose-response relationship, drug (539) 539
adrenal cortex hormones - therapeutic use (538) 538
anti-inflammatory agents - therapeutic use (532) 532
drug combinations (530) 530
albuterol - administration & dosage (519) 519
medicine, general & internal (515) 515
anti-asthmatic agents - therapeutic use (512) 512
salmeterol xinafoate (503) 503
child, preschool (490) 490
glucocorticoids (489) 489
care and treatment (484) 484
chronic obstructive pulmonary disease (473) 473
glucocorticoids - administration & dosage (465) 465
administration, intranasal (454) 454
copd (452) 452
lung diseases, obstructive (433) 433
budesonide - administration & dosage (430) 430
inflammation (413) 413
safety (408) 408
drug administration schedule (407) 407
research (407) 407
administration, topical (406) 406
therapy (405) 405
quality of life (396) 396
analysis (361) 361
severity of illness index (354) 354
adrenal cortex hormones - adverse effects (352) 352
nebulizers and vaporizers (352) 352
albuterol - therapeutic use (349) 349
cross-over studies (348) 348
pediatrics (343) 343
time factors (338) 338
exacerbations (336) 336
randomized controlled trials as topic (330) 330
pulmonary disease, chronic obstructive - physiopathology (323) 323
forced expiratory volume - drug effects (319) 319
young adult (315) 315
quality-of-life (310) 310
abridged index medicus (306) 306
risk factors (306) 306
bronchodilator agents - adverse effects (303) 303
anti-asthmatic agents - adverse effects (296) 296
lung-function (294) 294
glucocorticoids - therapeutic use (292) 292
forced expiratory volume (291) 291
persistent asthma (291) 291
animals (290) 290
anti-inflammatory agents - adverse effects (288) 288
respiratory function tests (279) 279
formoterol (276) 276
allergic rhinitis (274) 274
studies (274) 274
rhinitis, allergic, seasonal - drug therapy (270) 270
airway inflammation (269) 269
adults (265) 265
androstadienes - pharmacology (262) 262
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5183) 5183
German (66) 66
French (55) 55
Japanese (50) 50
Spanish (16) 16
Chinese (11) 11
Polish (8) 8
Russian (8) 8
Danish (6) 6
Dutch (6) 6
Italian (6) 6
Swedish (6) 6
Romanian (5) 5
Finnish (2) 2
Czech (1) 1
Korean (1) 1
Norwegian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane Database of Systematic Reviews, ISSN 1469-493X, 08/2017, Volume 2017, Issue 8, p. CD002311
Background Bronchopulmonary dysplasia (BPD), defined as oxygen dependence at 36 weeks postmenstrual age (PMA), remains an important complication of... 
CONTROLLED-TRIAL | INHALED GLUCOCORTICOID THERAPY | LOW-BIRTH-WEIGHT | Humans | PREMATURE-INFANTS | Infant | Fluticasone | CHRONIC LUNG-DISEASE | MEDICINE, GENERAL & INTERNAL | Anti-Inflammatory Agents [administration & dosage] | Dexamethasone [administration & dosage] | Bronchopulmonary Dysplasia [etiology | Glucocorticoids [administration & dosage] | drug therapy | Budesonide [administration & dosage] | Administration, Inhalation | prevention& control | ADRENAL-FUNCTION | BECLOMETHASONE DIPROPIONATE | Beclomethasone [administration & dosage] | Randomized Controlled Trials as Topic | Pneumonia [complications | METERED-DOSE INHALER | Newborn | Androstadienes [administration & dosage] | FLUTICASONE PROPIONATE | analogs & derivatives | Infant, Premature | DOUBLE-BLIND | Fluocinolone Acetonide [administration & dosage | Beclomethasone - administration & dosage | Fluocinolone Acetonide - administration & dosage | Glucocorticoids - administration & dosage | Dexamethasone - administration & dosage | Fluocinolone Acetonide - analogs & derivatives | Bronchopulmonary Dysplasia - prevention & control | Pneumonia - drug therapy | Fluticasone - administration & dosage | Pneumonia - complications | Anti-Inflammatory Agents - administration & dosage | Budesonide - administration & dosage | Bronchopulmonary Dysplasia - etiology | Infant, Newborn
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2018, Volume 378, Issue 18, pp. 1671 - 1680
The frequency of COPD exacerbations during treatment with a triple inhaler — delivering a long-acting beta-agonist (LABA), a long-acting muscarinic antagonist... 
MEDICINE, GENERAL & INTERNAL | OBSTRUCTIVE PULMONARY-DISEASE | IMPACT | PARALLEL-GROUP | DOUBLE-BLIND | TIOTROPIUM | RANDOMIZED CONTROLLED-TRIAL | FLUTICASONE PROPIONATE/SALMETEROL | SALMETEROL | Glucocorticoids - administration & dosage | Bronchodilator Agents - administration & dosage | Humans | Middle Aged | Muscarinic Antagonists - adverse effects | Benzyl Alcohols - administration & dosage | Hospitalization - statistics & numerical data | Male | Dyspnea - etiology | Quinuclidines - administration & dosage | Chlorobenzenes - administration & dosage | Adrenergic beta-Agonists - administration & dosage | Adult | Female | Bronchodilator Agents - adverse effects | Adrenergic beta-Agonists - adverse effects | Glucocorticoids - adverse effects | Double-Blind Method | Drug Administration Schedule | Administration, Inhalation | Pulmonary Disease, Chronic Obstructive - complications | Muscarinic Antagonists - administration & dosage | Androstadienes - administration & dosage | Intention to Treat Analysis | Quality of Life | Dyspnea - drug therapy | Aged | Drug Combinations | Pulmonary Disease, Chronic Obstructive - drug therapy | Treatment outcome | Lung diseases, Obstructive | Care and treatment | Usage | Analysis | Diagnosis | Inhalers | Pneumonia | Acetylcholine receptors (muscarinic) | Glucocorticoids | Lung diseases | Critical care | Fluticasone | Patients | Quality of life | Medicine | Hospitals | Obstructive lung disease | Population | Chronic obstructive pulmonary disease | Drug dosages | Life Sciences | Human health and pathology | Pulmonology and respiratory tract
Journal Article
Journal Article
Cochrane database of systematic reviews (Online), ISSN 1469-493X, 2011, Volume 2011, Issue 12, p. CD007033
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2010, Volume 362, Issue 11, pp. 975 - 985
Journal Article
The Cochrane database of systematic reviews, ISSN 1469-493X, 2013, Volume 8, Issue 12, p. CD006826
Background Both long-acting beta(2)-agonists and inhaled corticosteroids have been recommended in guidelines for the treatment of chronic obstructive pulmonary... 
Adrenal Cortex Hormones [administration & dosage; adverse effects] | COST-EFFECTIVENESS | Adrenergic beta-Agonists [administration & dosage; adverse effects] | EFFICACY | Humans | SALMETEROL/FLUTICASONE PROPIONATE | Steroids [administration & dosage; adverse effects] | Pneumonia [chemically induced] | Randomized Controlled Trials as Topic | SALMETEROL | Bronchodilator Agents [administration & dosage; adverse effects] | Pulmonary Disease, Chronic Obstructive [drug therapy; mortality] | MEDICINE, GENERAL & INTERNAL | FLUTICASONE PROPIONATE | COMBINED MOMETASONE FUROATE | FIXED-DOSE COMBINATION | Drug Therapy, Combination | CHINESE PATIENTS | Drug Combinations | Nebulizers and Vaporizers | HEALTH-STATUS | COPD | Pulmonary Disease, Chronic Obstructive - mortality | Steroids - administration & dosage | Ethanolamines - adverse effects | Formoterol Fumarate | Bronchodilator Agents - administration & dosage | Ethanolamines - administration & dosage | Drug Therapy, Combination - adverse effects | Adrenergic beta-2 Receptor Agonists - adverse effects | Pneumonia - chemically induced | Albuterol - administration & dosage | Bronchodilator Agents - adverse effects | Steroids - adverse effects | Albuterol - analogs & derivatives | Adrenal Cortex Hormones - adverse effects | Drug Therapy, Combination - methods | Androstadienes - administration & dosage | Budesonide - adverse effects | Adrenergic beta-2 Receptor Agonists - administration & dosage | Budesonide - administration & dosage | Fluticasone-Salmeterol Drug Combination | Androstadienes - adverse effects | Albuterol - adverse effects | Adrenal Cortex Hormones - administration & dosage | Pulmonary Disease, Chronic Obstructive - drug therapy
Journal Article
Journal Article
Cochrane database of systematic reviews (Online), ISSN 1469-493X, 2012, Volume 2012, Issue 9, p. CD006829
Background Both inhaled steroids (ICS) and long-acting beta(2)-agonists (LABA) are used in the management of chronic obstructive pulmonary disease (COPD). This... 
Adrenal Cortex Hormones [administration & dosage; adverse effects] | COST-EFFECTIVENESS | Adrenergic beta-Agonists [administration & dosage; adverse effects] | CLINICAL-TRIAL | Humans | FLUTICASONE PROPIONATE/SALMETEROL 250/50 | SALMETEROL/FLUTICASONE PROPIONATE | COPD EXACERBATIONS | LUNG-FUNCTION | RANDOMIZED CONTROLLED-TRIAL | Pneumonia [chemically induced] | Randomized Controlled Trials as Topic | SALMETEROL | Bronchodilator Agents [administration & dosage; adverse effects] | Pulmonary Disease, Chronic Obstructive [drug therapy; mortality] | MEDICINE, GENERAL & INTERNAL | METERED-DOSE INHALER | Quality of Life | Adult | Drug Therapy, Combination | 50 MU-G | Drug Combinations | Nebulizers and Vaporizers | Pulmonary Disease, Chronic Obstructive - mortality | Ethanolamines - adverse effects | Formoterol Fumarate | Bronchodilator Agents - administration & dosage | Fluticasone | Ethanolamines - administration & dosage | Pneumonia - chemically induced | Adrenergic beta-Agonists - administration & dosage | Albuterol - administration & dosage | Bronchodilator Agents - adverse effects | Adrenergic beta-Agonists - adverse effects | Salmeterol Xinafoate | Albuterol - analogs & derivatives | Adrenal Cortex Hormones - adverse effects | Drug Therapy, Combination - methods | Androstadienes - administration & dosage | Budesonide - adverse effects | Budesonide - administration & dosage | Androstadienes - adverse effects | Albuterol - adverse effects | Adrenal Cortex Hormones - administration & dosage | Pulmonary Disease, Chronic Obstructive - drug therapy
Journal Article
The Cochrane database of systematic reviews, ISSN 1469-493X, 2013, Volume 5, Issue 5, p. CD007891
Journal Article